Director Rothbaum Reports a $26.5 Million IOVA Purchase

Steve Strazza
September 18, 2023

From the Desk of Steve Strazza

The most significant insider purchase on today’s list comes from Wayne P. Rothbaum, director of Iovance Biotherapeutics $IOVA.

Rothbaum declared a $26.5 million IOVA purchase in a Form 4 filing.

Article Sales Message

Know the trading behavior of …

  • Senators
  • House Of Representatives
  • C-Suite Executives
  • Hedge Fund Managers
  • Other Big-Power Players

Our experienced team of analysts work through the Form 4, 13D and 13G filings to provide you a list of the best trade ideas.

You need to have a subscription to access this content in full.

Log in or subscribe
Filed Under: